InSphero at the MPS World Summit 2026
Join us at the MPS World Summit 2026 in Washington, DC, where the global community comes together to advance microphysiological systems and human-relevant models.
We’re looking forward to engaging with the field around how technologies are evolving beyond standalone models toward more integrated, workflow-oriented approaches. We combine our 3D in vitro platforms with the expertise and infrastructure needed to support consistent, scalable, and decision-ready outcomes across the research pipeline.
Don’t miss the opportunity to connect, exchange perspectives, and learn how these approaches can be applied within your own workflows.
Â
Explore all our activities taking place during MPS Summit 2026Â from Tuesday, May 26th to Friday, May 29th. See you soon!Â
Meet our Team at the MPS World Summit 2026
Jan Lichtenberg, PhD
Jan Lichtenberg, PhD
CEO and Co-Founder
Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer
Olivier Frey, PhD
Olivier Frey, PhD
Chief Operating Officer & Chief Technology Officer
Anna Borgström, PhD
Anna Borgström, PhD
Deputy VP Liver Safety
Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager
Alexandra Title, PhD
Alexandra Title, PhD
Vice President, Islet Biology
Arnab China, PhD
Arnab China, PhD
Business Development Manager
Our Booth at the MPS World Summit 2026
Visit our booth #521 and discover our scalable, reliable and reproducible 3D in vitro technology designed to empower researchers and accelerate a new era of breakthrough therapies.
Educational Workshop at the MPS World Summit 2026
Adding Immune Competence to 3D In Vitro Disease Models: Finding the Sweet Spot Between Biological Complexity and Scalability Using Akura™ and Gri3D® Technology
Date: Tuesday, May 26 2026 | 8:00 am – 11:30 am
Location: East Salon C
Â
Anna Borgström, PhD
Anna Borgström, PhD
Deputy VP Liver Safety
Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager
Breakfast Session at the MPS World Summit 2026
Inside the NAMs Workflow: Real-World Implementation Lessons in Pharma
Date: Wednesday, May 27 2026 | 7:30 am – 8:30 am
Location: Room 203A
Â
Presentations, Talks & Panel Discussions at the MPS World Summit 2026
Scientific Talk: A 3D Imaging Toolbox for Islet Biology: Utilization of 3D High-Content Confocal Microscopy for the Characterization of Reaggregated Human Islets in Health and Disease
Session: Session 2.4 Modeling Human Disease: Metabolic DisordersÂ
Date: Thursday, May 28 2026 | 11:30 am – 1:00 pm
Alexandra Title, PhD
Alexandra Title, PhD
Vice President, Islet Biology
Workshop: Advancing Global Alignment on NAMs: Regulatory Roadmaps, Challenges and Opportunities
Role: PanelistÂ
Date: Tuesday, May 26 2026 | 12:00pm – 12:30pm
Virtual Control Groups: A Data-Driven Leap Forward in Nonclinical Study Deisgn
Role: Presenter
Date: Thursday, May 28 2026 | 8:00 am – 9:00 am
Session 4.4 Collaborative Validation Exercises: Developer-End User Dialogues
Role: ChairÂ
Date: Thursday, May 28 2026 | 11:30 am – 1:00 pm
Roundtable: Stakeholders Response to the Workshop: Advancing Global Alignment on NAMs: Regulatory Roadmaps, Challenges and Opportunities
Role: SpeakerÂ
Date: Thursday, May 28 2026 | 6:30 pm – 7:30 pm
Jan Lichtenberg, PhD
Jan Lichtenberg, PhD
CEO and Co-Founder
Roundtable: MPS and M-CELS: Now and in the Future
Role: Panelist
Date: Thursday, May 28 2026 | 6:30 pm – 7:30 pm
Session 4.5 Regulatory Acceptance Case Studies: Developer-Regulator Dialogues
Role: ChairÂ
Date: Thursday, May 28 2026 |2:30 pm – 4:00 pm
Session 4.7 Scalability, Reproducibility, and Manufacturing-Readiness Strategies
Role: ChairÂ
Date: Friday, May 29 2026 | 11:00 am – 1:00 pm
Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer
Posters at the MPS World Summit 2026
"Scalable and reproducible 3D tumor spheroid platform for assessing therapeutic antibody penetration and efficacy"
Date: Wednesday, May 27 2026 | 10:00 – 11:30 am
Poster Number: 124
Abstract Number: 608
Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer
"Leveraging low-input RNA-sequencing in human and animal liver microtissues to characterize mechanisms of drug-induced liver injury"
Date: Thursday, May 28 2026 | 4:00 – 5:30 pm
Poster Number: 125
Abstract Number: 225
Anna Borgström, PhD
Anna Borgström, PhD
Deputy VP Liver Safety
"Evaluation of drug-induced liver injury of trovafloxacin and chlorpromazine in human InSightâ„¢ 3D MASLD spheroid model"
Date: Thursday, May 28 2026 | 4:00 – 5:30 pm
Poster Number: 149
Abstract Number: 623
Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager
"Multiparametric assays in 3D human liver microtissues: towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment"
Date: Thursday, May 28 2026 | 4:00 – 5:30 pm
Poster Number: 147
Abstract Number: 605
Olivier Frey, PhD
Olivier Frey, PhD
Chief Operating Officer & Chief Technology Officer